Lista de obras - Masumi Eto - Dominio Público Uruguay

A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes

artículo científico publicado en 1999

Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells

artículo científico publicado en 2006

Agonists Trigger G Protein-mediated Activation of the CPI-17 Inhibitor Phosphoprotein of Myosin Light Chain Phosphatase to Enhance Vascular Smooth Muscle Contractility

artículo científico publicado en 2000

Assay for Three-Way Interaction of Protein Phosphatase-1 (Glc7) With Regulatory Subunits Plus Phosphatase Inhibitor-2

artículo científico publicado en 2007

Assembly of MYPT1 with protein phosphatase-1 in fibroblasts redirects localization and reorganizes the actin cytoskeleton

artículo científico publicado en 2005

Association of the tensin N-terminal protein-tyrosine phosphatase domain with the alpha isoform of protein phosphatase-1 in focal adhesions

artículo científico publicado en 2007

CPI-17-deficient smooth muscle of chicken

artículo científico publicado en 2004

Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle

artículo científico publicado en 2007

Caffeine relaxes smooth muscle through actin depolymerization

artículo científico publicado en 2012

Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor

artículo científico publicado en 2002

Computational simulation for interactions of nano-molecules: The phospho-pivot modeling algorithm for prediction of interactions between a phospho-protein and its receptor

scholarly article by Fumiko Matsuzawa et al published January 2005 in Science and Technology of Advanced Materials

Correction to: Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology

artículo científico publicado en 2017

Defining the Structural Determinants and a Potential Mechanism for Inhibition of Myosin Phosphatase by the Protein Kinase C-potentiated Inhibitor Protein of 17 kDa

artículo científico publicado en 2001

Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosph

artículo científico publicado en 2003

Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threonine residue

artículo científico publicado en 2003

Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction

artículo científico publicado en 2017

Domains of type 1 protein phosphatase inhibitor-2 required for nuclear and cytoplasmic localization in response to cell-cell contact

artículo científico publicado en 2002

Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells

artículo científico publicado en 2011

Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling

artículo científico publicado en 2012

Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle

artículo científico publicado en 2001

Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation

artículo científico publicado en 2009

F-actin clustering and cell dysmotility induced by the pathological W148R missense mutation of filamin B at the actin-binding domain

artículo científico publicado en 2015

Heat shock augments angiotensin II-induced vascular contraction through increased production of reactive oxygen species

artículo científico publicado en 2010

Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms

artículo científico publicado en 2001

Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation

artículo científico publicado en 2002

Interleukin 6 mediates production of interleukin 10 in metastatic melanoma.

artículo científico publicado en 2011

Molecular cloning of a novel phosphorylation‐dependent inhibitory protein of protein phosphatase‐1 (CPI17) in smooth muscle: its specific localization in smooth muscle1 ⬇️

artículo científico publicado el 30 de junio de 1997

Molecular mechanism of telokin-mediated disinhibition of myosin light chain phosphatase and cAMP/cGMP-induced relaxation of gastrointestinal smooth muscle

artículo científico publicado en 2012

Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1

artículo científico publicado en 2009

Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells

artículo científico publicado en 2013

Phospho-Pivot Modeling Predicts Specific Interactions of Protein Phosphatase-1 with a Phospho-Inhibitor Protein CPI-17

artículo científico publicado en 2005

Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits

artículo científico publicado en 2004

Phosphorylation of protein phosphatase type-1 inhibitory proteins by integrin-linked kinase and cyclic nucleotide-dependent protein kinases

artículo científico publicado en 2003

Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase

scientific journal article

Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle

artículo científico publicado en 2003

Phosphorylation of the myosin-binding subunit of myosin phosphatase by Raf-1 and inhibition of phosphatase activity

artículo científico publicado en 2002

Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction

artículo científico publicado en 2009

Phosphorylation-induced conformational change responsible for the function of a myosin phosphatase inhibitor, CPI-17

Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor

artículo científico publicado en 2007

Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle

article by L Li et al published 1 May 1998 in Journal of Physiology

Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology.

artículo científico publicado en 2017

ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK.

artículo científico publicado en 2009

RSK2 contributes to myogenic vasoconstriction of resistance arteries by activating smooth muscle myosin and the Na/H exchanger

artículo científico publicado en 2018

Reactivities of Cys707 (SH1) in Intermediate States of Myosin Subfragment-1 ATPase

article

Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells

artículo científico publicado en 2012

Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1.

artículo científico publicado en 2014

Reconstitution of protein kinase C-induced contractile Ca2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle

Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors

artículo científico publicado en 2009

Remodeling of the rat distal colon in diabetes: function and ultrastructure

artículo científico publicado en 2015

Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants

artículo científico publicado en 2003

RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells

artículo científico publicado en 2005

RhoA-mediated Ca2+ sensitization in erectile function

artículo científico publicado en 2002

Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation

artículo científico publicado en 2001

Solution structure of the inhibitory phosphorylation domain of myosin phosphatase targeting subunit 1

artículo científico publicado en 2009

Thromboxane A2-induced bi-directional regulation of cerebral arterial tone

artículo científico publicado en 2008

Uncoupling of GPCR and RhoA-induced Ca2+-sensitization of chicken amnion smooth muscle lacking CPI-17.

artículo científico publicado en 2004

Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1).

artículo científico publicado en 2017

Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle

artículo científico publicado en 2009

Lista de obras de Masumi Eto

A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes

Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells

Agonists Trigger G Protein-mediated Activation of the CPI-17 Inhibitor Phosphoprotein of Myosin Light Chain Phosphatase to Enhance Vascular Smooth Muscle Contractility

Assay for Three-Way Interaction of Protein Phosphatase-1 (Glc7) With Regulatory Subunits Plus Phosphatase Inhibitor-2

Assembly of MYPT1 with protein phosphatase-1 in fibroblasts redirects localization and reorganizes the actin cytoskeleton

Association of the tensin N-terminal protein-tyrosine phosphatase domain with the alpha isoform of protein phosphatase-1 in focal adhesions

CPI-17-deficient smooth muscle of chicken

Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle

Caffeine relaxes smooth muscle through actin depolymerization

Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor

Computational simulation for interactions of nano-molecules: The phospho-pivot modeling algorithm for prediction of interactions between a phospho-protein and its receptor

Correction to: Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology

Defining the Structural Determinants and a Potential Mechanism for Inhibition of Myosin Phosphatase by the Protein Kinase C-potentiated Inhibitor Protein of 17 kDa

Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosph

Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threonine residue

Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction

Domains of type 1 protein phosphatase inhibitor-2 required for nuclear and cytoplasmic localization in response to cell-cell contact

Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells

Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling

Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle

Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation

F-actin clustering and cell dysmotility induced by the pathological W148R missense mutation of filamin B at the actin-binding domain

Heat shock augments angiotensin II-induced vascular contraction through increased production of reactive oxygen species

Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms

Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation

Interleukin 6 mediates production of interleukin 10 in metastatic melanoma.

Molecular cloning of a novel phosphorylation‐dependent inhibitory protein of protein phosphatase‐1 (CPI17) in smooth muscle: its specific localization in smooth muscle1 ⬇️

Molecular mechanism of telokin-mediated disinhibition of myosin light chain phosphatase and cAMP/cGMP-induced relaxation of gastrointestinal smooth muscle

Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1

Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells

Phospho-Pivot Modeling Predicts Specific Interactions of Protein Phosphatase-1 with a Phospho-Inhibitor Protein CPI-17

Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits

Phosphorylation of protein phosphatase type-1 inhibitory proteins by integrin-linked kinase and cyclic nucleotide-dependent protein kinases

Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase

Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle

Phosphorylation of the myosin-binding subunit of myosin phosphatase by Raf-1 and inhibition of phosphatase activity

Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction

Phosphorylation-induced conformational change responsible for the function of a myosin phosphatase inhibitor, CPI-17

Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor

Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle

Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology.

ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK.

RSK2 contributes to myogenic vasoconstriction of resistance arteries by activating smooth muscle myosin and the Na/H exchanger

Reactivities of Cys707 (SH1) in Intermediate States of Myosin Subfragment-1 ATPase

Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells

Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1.

Reconstitution of protein kinase C-induced contractile Ca2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle

Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors

Remodeling of the rat distal colon in diabetes: function and ultrastructure

Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants

RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells

RhoA-mediated Ca2+ sensitization in erectile function

Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation

Solution structure of the inhibitory phosphorylation domain of myosin phosphatase targeting subunit 1

Thromboxane A2-induced bi-directional regulation of cerebral arterial tone

Uncoupling of GPCR and RhoA-induced Ca2+-sensitization of chicken amnion smooth muscle lacking CPI-17.

Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1).

Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle